Patent · US Active

6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes

US11633403B2 · kind B2 · utility

2Cited by

0References

20Claims

0Family size

Assignee

Sprint Bioscience AB · SE

Inventors

Jessica Martinsson · Sollentuna, SE
Martin Andersson · Huddinge, SE
Johan Lindström · Huddinge, SE
Rickard Forsblom · Tullinge, SE
Fredrik Rahm · Huddinge, SE
Tobias Ginman · Tullinge, SE
Jenny Viklund · Kungshättan, SE

Key dates

Filing date	Jun 29, 2021
Grant date	Apr 25, 2023
Priority date	—
Expiry date	Jul 21, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R1, R2, R3 and R4 are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.